Early antibody therapy can induce long-lasting immunity to SHIV-Reference-Cited by-同舟云学术

Early antibody therapy can induce long-lasting immunity to SHIV

Published:2017-03 Issue:7646 Volume:543 Page:559-563
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Nishimura Yoshiaki,Gautam Rajeev,Chun Tae-Wook,Sadjadpour Reza,Foulds Kathryn E.,Shingai Masashi,Klein Florian,Gazumyan Anna,Golijanin Jovana,Donaldson Mitzi,Donau Olivia K.,Plishka Ronald J.,Buckler-White Alicia,Seaman Michael S.,Lifson Jeffrey D.,Koup Richard A.,Fauci Anthony S.,Nussenzweig Michel C.,Martin Malcolm A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature21435.pdf

Reference36 articles.

1. Barouch, D. H. et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503, 224–228 (2013)

2. Bolton, D. L. et al. Human immunodeficiency virus type 1 monoclonal antibodies suppress acute simian-human immunodeficiency virus viremia and limit seeding of cell-associated viral reservoirs. J. Virol. 90, 1321–1332 (2016)

3. Caskey, M. et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature 522, 487–491 (2015)

4. Gautam, R. et al. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Nature 533, 105–109 (2016)

5. Halper-Stromberg, A. et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell 158, 989–999 (2014)

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data;PLOS Computational Biology;2024-09-10

2. Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection;Nature Communications;2024-08-29

3. Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention;Nature Immunology;2024-08-28

4. Impact of antiretroviral therapy during primary HIV infection on T‐cell immunity after treatment interruption;European Journal of Immunology;2024-08-13

5. Modelling HIV-1 control and remission;npj Systems Biology and Applications;2024-08-08